Middle East and Africa Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)); Allergy type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, and Others); Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Country
The Middle East & Africa Allergy immunotherapies market was valued at US$ 137.87 million in 2019 and is projected to reach US$ 297.62 million by 2027; it is expected to grow at a CAGR of 10.2% during the forecast period.
The increasing prevalence of allergic disorders and technological advancements in sublingual dosage formulations are the key factors fueling the allergy immunotherapies market growth.
Allergen immunotherapy is a medical treatment useful for environmental allergies, insect bite allergies, and asthma. This involves the regular administration of gradually increasing the dose of allergen extracts into the patient’s body over a certain period. The Allergy Immunotherapy market in the Middle East and Africa region is expected to exhibit the highest growth rate due to the increased incidence of allergy people in developing countries like Saudi Arabia and South Africa. In the recent report of the National Health and Nutrition Examination Survey, 54% of the population had positive test responses to one or more allergens. Allergic disorders are mostly treated with immunotherapy; thus, the growing prevalence of allergic diseases drives the growth of the market. Also, the growing unmet needs of novel targeted drugs, which are used to treat the allergic conditions, will create growth opportunities for the market players. Many companies are investing in research and development to develop targeted drugs for various allergic disorders.
The Covid-19 pandemic has harmed Middle East and Africa allergy immunotherapies market size, with small and medium scale companies struggling to sustain their businesses in the near-term future. Industry leaders are now focusing on creating new business practices to deal with crises like Covid-19 pandemic.
Middle East and Africa Allergy Immunotherapies Market Revenue and Forecast to 2027 (US$ Mn)
Get more information on this report :
MIDDLE EAST AND AFRICA ALLERGY IMMUNOTHERAPIES MARKET SEGMENTATION
By Treatment
- Subcutaneous Immunotherapy (SCIT)
- Sublingual Immunotherapy (SLIT)
By Allergy Type
- Allergic Rhinitis
- Asthma
- Food Allergy
- Venom Allergy
- Others
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Country
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Company Profiles
- HAL Allergy B.V.
- ALK Abello A/S
- Stallergenes Greer
- Anergis
- Circassia
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Allergy Immunotherapies Market – By Treatment
1.3.2 Middle East and Africa Allergy Immunotherapies Market – By Allergy Type
1.3.3 Middle East and Africa Allergy Immunotherapies Market – By Distribution Channel
1.3.4 Middle East and Africa Allergy Immunotherapies Market – By Geography
2. Allergy Immunotherapies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Allergy Immunotherapies Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa (MEA) – PEST Analysis
4.3 Expert Opinion
5. Allergy immunotherapies Market – Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Prevalence of Allergic Disorders
5.1.2 Technological Advancements in Sublingual Dosage Formulations
5.2 Key Market Restraint
5.2.1 Drawbacks Associated with the Use of Allergy Immunotherapy
5.2.2 Regulatory Variations Across Regions
5.3 Key Market Opportunities
5.3.1 Presence of Strong Product Pipeline
5.4 Future Trends
5.4.1 Increasing FDA Approvals for Drugs
5.5 Impact Analysi
6. Allergy Immunotherapies Market – Middle East and Africa Analysis
6.1 Middle East and Africa Allergy Immunotherapies Market Revenue Forecast and Analysis
7. Allergy Immunotherapies Market Analysis– by Treatment
7.1 Overview
7.2 Allergy Immunotherapies Market Share, By Treatment, 2019 & 2027 (%)
7.3 Subcutaneous Immunotherapy (SCIT)
7.3.1 Overview
7.3.2 Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
7.4 Sublingual Immunotherapy (SLIT)
7.4.1 Overview
7.4.2 Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
8. Allergy Immunotherapies Market Analysis– by Allergy Type
8.1 Overview
8.2 Allergy Immunotherapies Market Share, By Allergy Type, 2019 & 2027 (%)
8.3 Allergic Rhinitis
8.3.1 Overview
8.3.2 Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
8.4 Asthma
8.4.1 Overview
8.4.2 Asthma Market Revenue and Forecasts to 2027 (US$ Million)
8.5 Food Allergy
8.5.1 Overview
8.5.2 Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.6 Venom Allergy
8.6.1 Overview
8.6.2 Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
8.7 Other Allergies
8.7.1 Overview
8.7.2 Others Market Revenue and Forecasts to 2027 (US$ Million)
9. Allergy Immunotherapies Market Analysis– by Distribution Channel
9.1 Overview
9.2 Allergy Immunotherapies Market Share, By Distribution Channel, 2019 & 2027 (%)
9.3 Hospital Pharmacy
9.3.1 Overview
9.3.2 Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.4 Retail Pharmacy
9.4.1 Overview
9.4.2 Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
9.5 Online Pharmacy
9.5.1 Overview
9.5.2 Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
10. Allergy Immunotherapies Market Analysis and Forecasts To 2027 – Geographical Analysis
10.1 Middle East & Africa: Allergy immunotherapies market
10.1.1 Overview
10.1.2 Middle East & Africa: Allergy immunotherapies market - Revenue and Forecast to 2027 (US$ Million)
10.1.3 Middle East and Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.4 Middle East and Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.5 Middle East and Africa Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.6 Middle East and Africa: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
10.1.7 Saudi Arabia: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 Saudi Arabia: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 Saudi Arabia Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.7.3 Saudi Arabia Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.7.4 Saudi Arabia Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.8 UAE: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 UAE: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 UAE Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.8.3 UAE Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.8.4 UAE Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10.1.9 South Africa: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 South Africa: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 South Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 South Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 South Africa Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on Middle East and Africa Allergy Immunotherapies Market
11.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 ALK-Abelló A/S
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 AIMMUNE THERAPEUTICS, INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Stallergenes Greer
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 HAL Allergy B.V.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Johnson and Johnson Services, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Anergis
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 DBV Technologies
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Allergy Therapeutics
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 Glossary of Terms
LIST OF TABLES
Table 1. Middle East and Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 2. Middle East and Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 3. Middle East and Africa Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 4. Saudi Arabia Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 5. Saudi Arabia Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 6. Saudi Arabia Allergy immunotherapies market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 7. UAE Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million
Table 8. UAE Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 9. UAE Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 10. South Africa Allergy immunotherapies market, by Treatment – Revenue and Forecast to 2027 (USD Million)
Table 11. South Africa Allergy immunotherapies market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)
Table 12. South Africa Allergy Immunotherapies Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Glossary of Terms, Allergy Immunotherapies Market
LIST OF FIGURES
Figure 1. Allergy Immunotherapies Market Segmentation
Figure 2. Allergy Immunotherapies Market – By Geography
Figure 3. Middle East and Africa Allergy Immunotherapies Market Overview
Figure 4. Subcutaneous Immunotherapy (SCIT) Segment Held Largest Share of Allergy immunotherapies market
Figure 5. Middle East and Africa Allergy Immunotherapies Market- Leading Country Markets (US$ Million)
Figure 6. Middle East and Africa (MEA) PEST Analysis
Figure 7. Allergy immunotherapies Market Impact Analysis of Driver and Restraints
Figure 8. Middle East and Africa Allergy Immunotherapies Market – Revenue Forecast and Analysis – 2019- 2027
Figure 9. Allergy Immunotherapies Market Share, by Treatment, 2019 & 2027 (%)
Figure 10. Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 11. Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)
Figure 12. Allergy Immunotherapies Market Share, by Allergy Type, 2019 & 2027 (%)
Figure 13. Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)
Figure 14. Asthma Market Revenue and Forecasts to 2027 (US$ Million)
Figure 15. Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 16. Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 17. Others Market Revenue and Forecasts to 2027 (US$ Million)
Figure 18. Allergy Immunotherapies Market Share, by Distribution Channel, 2019 & 2027 (%)
Figure 19. Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 20. Retail Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 21. Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)
Figure 22. Middle East & Africa: Allergy immunotherapies market, by Key Country – Revenue (2019) (USD Million)
Figure 23. Middle East & Africa Allergy immunotherapies market Revenue and Forecast to 2027 (USD Million)
Figure 24. Middle East and Africa: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)
Figure 25. Saudi Arabia: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 26. UAE: Allergy immunotherapies market – Revenue and Forecast to 2027 (USD Million)
Figure 27. South Africa: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Impact of COVID-19 Pandemic on allergy immunotherapies market in Middle East and Africa
- HAL Allergy B.V.
- ALK Abello A/S
- Stallergenes Greer
- Anergis
- Circassia
- Determine prospective investment areas based on a detailed trend analysis of the Middle East & Africa allergy immunotherapy market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different Middle East & Africa allergy immunotherapy segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the Middle East & Africa allergy immunotherapy market, providing a clear picture of future opportunities that will help Analyse, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East & Africa immunotherapy market.